Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets Mylan Inc. (NYSE: MYL) announced that Mylan Pharmaceuticals Inc. has launched Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, the generic version of GlaxoSmithKline's (GSK) Paxil CR(R). As the first company to successfully file an abbreviated new drug application (ANDA) containing a paragraph IV certification for the 12.5 mg and 25 mg tablets, Mylan has earned 180 days of marketing exclusivity for these two strengths.
Source: www.medicalnewstoday.comDOR BioPharma Opens New Corporate Office In United Kingdom DOR BioPharma, Inc. (OTCBB: DORB), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced that it has opened a new corporate office in the United Kingdom (UK).
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 4:00 PM
